What is the current annual EBITDA of CRL?

As of today, CRL annual EBITDA is $804.45M

What is 1-year change in CRL annual EBITDA?

CRL annual EBITDA is down -13.37% year-over-year

What is 3-year change in CRL annual EBITDA?

CRL annual EBITDA is down -15.89% over the past 3 years

How far is CRL annual EBITDA from its all-time high?

CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on December 31, 2023

How does CRL annual EBITDA rank versus sector peers?

CRL annual EBITDA is higher than 92.33% of companies in Healthcare sector

When is CRL next annual earnings release?

As of today, the next annual earnings release for CRL has not been scheduled

What is the current quarterly EBITDA of CRL?

As of today, CRL quarterly EBITDA is $217.54M

What is CRL quarterly EBITDA most recent change?

CRL quarterly EBITDA was up +16.19% on June 27, 2026

What is 1-year change in CRL quarterly EBITDA?

CRL quarterly EBITDA is down -13.62% year-over-year

How far is CRL quarterly EBITDA from its all-time high?

CRL quarterly EBITDA is currently -17.97% below its historical high of $265.20M set on June 25, 2022

How does CRL quarterly EBITDA rank versus sector peers?

CRL quarterly EBITDA is higher than 91.96% of companies in Healthcare sector

When is CRL next earnings release?

The next earnings release for CRL is on November 4, 2026

What is the current TTM EBITDA of CRL?

As of today, CRL TTM EBITDA is $838.31M

What is CRL TTM EBITDA most recent change?

CRL TTM EBITDA was down -3.93% on June 27, 2026

What is 1-year change in CRL TTM EBITDA?

CRL TTM EBITDA is down -7.65% year-over-year

How far is CRL TTM EBITDA from its all-time high?

CRL TTM EBITDA is currently -14.73% below its historical high of $983.08M set on June 25, 2022

How does CRL TTM EBITDA rank versus sector peers?

CRL TTM EBITDA is higher than 92.25% of companies in Healthcare sector

When is CRL next earnings release?

The next earnings release for CRL is on November 4, 2026

CRL EBITDA History & Chart Since 1996

Annual EBITDA

$804.45M$124.17M-13.37%

December 27, 2025

Summary

Current Value: As of today, CRL annual EBITDA is $804.45M, down -13.37% on December 27, 2025
Historical Performance: CRL annual EBITDA is down -15.89% over the past 3 years, up +15.93% over the past 5 years
All-Time High Comparison: CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on December 31, 2023
3-Year Low Comparison: CRL annual EBITDA is at its 3-year low
Sector Comparison: CRL annual EBITDA is higher than 92.33% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

CRL Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 27, 25	$804.45M	-13.4%	-15.9%	+15.9%	+239.0%
Quarterly EBITDA	Jun 27, 26	$217.54M	-13.6%	-10.8%	-2.3%	+184.3%
TTM EBITDA	Jun 27, 26	$838.31M	-7.7%	-12.3%	+3.9%	+212.5%
Price	Aug 13, 26	$281.27	+81.5%	+31.1%	-31.6%	+812.0%
PE Ratio	Aug 13, 26	-	–	–	–	–
Annual Revenue	Dec 27, 25	$4.02B	-0.8%	+1.0%	+37.3%	+254.3%
Annual EPS	Dec 27, 25	-$2.91	-1560.5%	-130.7%	-140.5%	+45.9%
	Dec 27, 25	$401.14M	-29.2%	-38.5%	-12.6%	+179.2%
Annual Net Income	Dec 27, 25	-$142.16M	-662.1%	-128.9%	-138.9%	+57.5%

EBITDA Highs

CRL Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$975.26M	Dec 31, 23	-17.5%
5Y	$975.26M	Dec 31, 23	-17.5%
All	$975.26M	Dec 31, 23	-17.5%

EBITDA Lows

CRL Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$804.45M	Dec 27, 25	at low
5Y	$693.88M	N/A	+15.9%
All	$37.67M	Dec 1, 97	+2035.5%

EBITDA History

Year	Value	Change
2025	$804.45M	-13.4%
2024	$928.62M	-4.8%
2023	$975.26M	+2.0%
2022	$956.46M	+10.2%
2021	$867.97M	+25.1%
2020	$693.88M	+17.5%
2019	$590.69M	+13.6%
2018	$519.91M	+21.4%
2017	$428.32M	+9.1%
2016	$392.75M	+25.5%
2015	$312.97M	+6.1%
2014	$294.94M	+15.5%
2013	$255.46M	+0.9%
2012	$253.16M	-10.9%
2011	$284.14M	+19.7%

Year	Value	Change
2010	$237.31M	-13.8%
2009	$275.33M	-19.4%
2008	$341.42M	+8.9%
2007	$313.57M	+13.2%
2006	$276.96M	+1.6%
2005	$272.63M	+31.9%
2004	$206.63M	+21.7%
2003	$169.82M	+16.1%
2002	$146.25M	+20.8%
2001	$121.03M	+47.9%
2000	$81.83M	+53.3%
1999	$53.36M	+15.5%
1998	$46.22M	+22.7%
1997	$37.67M	-1.9%
1996	$38.42M	-

FAQ

What is the current annual EBITDA of CRL?: As of today, CRL annual EBITDA is $804.45M
What is 1-year change in CRL annual EBITDA?: CRL annual EBITDA is down -13.37% year-over-year
What is 3-year change in CRL annual EBITDA?: CRL annual EBITDA is down -15.89% over the past 3 years
How far is CRL annual EBITDA from its all-time high?: CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on December 31, 2023
How does CRL annual EBITDA rank versus sector peers?: CRL annual EBITDA is higher than 92.33% of companies in Healthcare sector
When is CRL next annual earnings release?: As of today, the next annual earnings release for CRL has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$217.54M$30.31M+16.19%

June 27, 2026

Summary

Current Value: As of today, CRL quarterly EBITDA is $217.54M, up +16.19% on June 27, 2026
Historical Performance: CRL quarterly EBITDA is down -13.62% year-over-year, down -10.79% over the past 3 years
All-Time High Comparison: CRL quarterly EBITDA is currently -17.97% below its historical high of $265.20M set on June 25, 2022
3-Year Low Comparison: CRL quarterly EBITDA is +16.19% above its 3-year low of $187.23M reached on March 28, 2026
Sector Comparison: CRL quarterly EBITDA is higher than 91.96% of companies in Healthcare sector

Performance

CRL Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 27, 26	$217.54M	+16.2%	-13.6%	-10.8%	-2.3%
Annual EBITDA	Dec 27, 25	$804.45M	–	-13.4%	-15.9%	+15.9%
TTM EBITDA	Jun 27, 26	$838.31M	-3.9%	-7.7%	-12.3%	+3.9%
Price	Aug 13, 26	$281.27	+72.7%	+81.5%	+31.1%	-31.6%
PE Ratio	Aug 13, 26	-	–	–	–	–
Quarterly Revenue	Jun 27, 26	$1.00B	+0.8%	-2.7%	-5.3%	+9.8%
Quarterly EPS	Jun 27, 26	-$0.03	+89.8%	-102.9%	-101.6%	-101.8%
	Jun 27, 26	$150.25M	+25.1%	+13.5%	-9.6%	-2.7%
Quarterly Net Income	Jun 27, 26	-$760.00K	+94.9%	-101.4%	-100.8%	-100.8%

Quarterly EBITDA Highs

CRL Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$251.84M	N/A	-13.6%
3Y	$255.69M	Jun 29, 24	-14.9%
5Y	$265.20M	Jun 25, 22	-18.0%
All	$265.20M	Jun 25, 22	-18.0%

Quarterly EBITDA Lows

CRL Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$187.23M	Mar 28, 26	+16.2%
3Y	$187.23M	Mar 28, 26	+16.2%
5Y	$187.23M	Mar 28, 26	+16.2%
All	$18.26M	Dec 30, 00	+1091.3%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$217.54M	+16.2%
Mar 2026	$187.23M	-5.1%
Dec 2025	$197.30M	-16.5%
Sep 2025	$236.25M	-6.2%
Jun 2025	$251.84M	+15.1%
Mar 2025	$218.88M	+9.2%
Dec 2024	$200.52M	-15.2%
Sep 2024	$236.55M	-7.5%
Jun 2024	$255.69M	+12.0%
Mar 2024	$228.33M	-1.1%
Dec 2023	$230.82M	-6.4%
Sep 2023	$246.57M	+1.1%
Jun 2023	$243.84M	-0.9%
Mar 2023	$246.03M	+2.8%
Dec 2022	$239.23M	+5.5%
Sep 2022	$226.68M	-14.5%
Jun 2022	$265.20M	+13.7%
Mar 2022	$233.19M	-7.2%
Dec 2021	$251.28M	+7.6%
Sep 2021	$233.42M	+4.9%
Jun 2021	$222.56M	+14.0%
Mar 2021	$195.16M	+0.4%
Dec 2020	$194.44M	-0.1%
Sep 2020	$194.61M	+35.5%
Jun 2020	$143.63M	-9.8%
Mar 2020	$159.20M	-6.7%
Dec 2019	$170.57M	+12.8%
Sep 2019	$151.21M	+6.0%
Jun 2019	$142.70M	+16.9%
Mar 2019	$122.10M	-16.4%
Dec 2018	$146.07M	+9.1%
Sep 2018	$133.83M	-0.2%
Jun 2018	$134.05M	+26.6%
Mar 2018	$105.92M	+9.9%
Dec 2017	$96.42M	-12.2%
Sep 2017	$109.82M	-3.6%
Jun 2017	$113.96M	+8.4%
Mar 2017	$105.11M	+0.5%
Dec 2016	$104.63M	+9.7%
Sep 2016	$95.42M	-4.0%
Jun 2016	$99.41M	+24.4%
Mar 2016	$79.89M	+2.7%
Dec 2015	$77.82M	-6.5%
Sep 2015	$83.25M	+4.1%
Jun 2015	$79.99M	+22.3%
Mar 2015	$65.42M	-14.9%
Dec 2014	$76.84M	+4.8%
Sep 2014	$73.33M	-6.8%
Jun 2014	$78.68M	+27.6%
Mar 2014	$61.66M	-3.7%
Dec 2013	$64.03M	-6.2%
Sep 2013	$68.24M	+6.8%
Jun 2013	$63.88M	+1.3%

Month	Value	Change
Mar 2013	$63.07M	+5.2%
Dec 2012	$59.97M	-4.4%
Sep 2012	$62.75M	-9.5%
Jun 2012	$69.34M	+7.2%
Mar 2012	$64.65M	-12.9%
Dec 2011	$74.27M	+26.7%
Sep 2011	$58.62M	-23.4%
Jun 2011	$76.50M	+19.4%
Mar 2011	$64.07M	-5.3%
Dec 2010	$67.63M	+12.7%
Sep 2010	$60.02M	+11.3%
Jun 2010	$53.94M	-4.4%
Mar 2010	$56.44M	-7.7%
Dec 2009	$61.14M	-14.8%
Sep 2009	$71.74M	-2.5%
Jun 2009	$73.56M	+6.6%
Mar 2009	$69.00M	-4.3%
Dec 2008	$72.10M	-4.9%
Sep 2008	$75.82M	-17.9%
Jun 2008	$92.34M	+7.6%
Mar 2008	$85.83M	+13.9%
Dec 2007	$75.39M	+4.6%
Sep 2007	$72.05M	+11.1%
Jun 2007	$64.86M	-13.1%
Mar 2007	$74.63M	+35.9%
Dec 2006	$54.91M	-23.9%
Sep 2006	$72.20M	+10.6%
Jun 2006	$65.27M	-2.4%
Mar 2006	$66.84M	+1.4%
Dec 2005	$65.95M	-3.6%
Sep 2005	$68.41M	+13.0%
Jun 2005	$60.53M	-14.5%
Mar 2005	$70.82M	+26.6%
Dec 2004	$55.93M	+11.3%
Sep 2004	$50.25M	-3.2%
Jun 2004	$51.90M	+9.6%
Mar 2004	$47.35M	+8.3%
Dec 2003	$43.73M	+5.4%
Sep 2003	$41.48M	-3.5%
Jun 2003	$43.01M	+3.6%
Mar 2003	$41.52M	+10.5%
Dec 2002	$37.56M	-3.3%
Sep 2002	$38.85M	+7.9%
Jun 2002	$36.00M	+6.4%
Mar 2002	$33.84M	-0.4%
Dec 2001	$33.97M	+9.0%
Sep 2001	$31.17M	+0.3%
Jun 2001	$31.08M	+25.3%
Mar 2001	$24.81M	+35.9%
Dec 2000	$18.26M	-17.4%
Sep 2000	$22.11M	-1.6%
Jun 2000	$22.46M	+7.0%
Mar 2000	$20.99M	-

FAQ

What is the current quarterly EBITDA of CRL?: As of today, CRL quarterly EBITDA is $217.54M
What is CRL quarterly EBITDA most recent change?: CRL quarterly EBITDA was up +16.19% on June 27, 2026
What is 1-year change in CRL quarterly EBITDA?: CRL quarterly EBITDA is down -13.62% year-over-year
How far is CRL quarterly EBITDA from its all-time high?: CRL quarterly EBITDA is currently -17.97% below its historical high of $265.20M set on June 25, 2022
How does CRL quarterly EBITDA rank versus sector peers?: CRL quarterly EBITDA is higher than 91.96% of companies in Healthcare sector
When is CRL next earnings release?: The next earnings release for CRL is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$838.31M$34.31M-3.93%

June 27, 2026

Summary

Current Value: As of today, CRL TTM EBITDA is $838.31M, down -3.93% on June 27, 2026
Historical Performance: CRL TTM EBITDA is down -7.65% year-over-year, down -12.29% over the past 3 years
All-Time High Comparison: CRL TTM EBITDA is currently -14.73% below its historical high of $983.08M set on June 25, 2022
3-Year Low Comparison: CRL TTM EBITDA is at its 3-year low
Sector Comparison: CRL TTM EBITDA is higher than 92.25% of companies in Healthcare sector

Performance

CRL Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 27, 26	$838.31M	-3.9%	-7.7%	-12.3%	+3.9%
Annual EBITDA	Dec 27, 25	$804.45M	–	-13.4%	-15.9%	+15.9%
Quarterly EBITDA	Jun 27, 26	$217.54M	+16.2%	-13.6%	-10.8%	-2.3%
Price	Aug 13, 26	$281.27	+72.7%	+81.5%	+31.1%	-31.6%
PE Ratio	Aug 13, 26	-	–	–	–	–
TTM Revenue	Jun 27, 26	$4.00B	-0.7%	-0.7%	-4.3%	+22.2%
TTM EPS	Jun 27, 26	-$4.85	-29.0%	-266.3%	-151.5%	-162.5%
	Jun 27, 26	$540.42M	+3.4%	+13.2%	-16.7%	-2.9%
TTM Net Income	Jun 27, 26	-$236.30M	-29.2%	-264.2%	-148.2%	-159.0%

TTM EBITDA Highs

CRL TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$907.79M	N/A	-7.7%
3Y	$975.66M	Sep 30, 23	-14.1%
5Y	$983.08M	Jun 25, 22	-14.7%
All	$983.08M	Jun 25, 22	-14.7%

TTM EBITDA Lows

CRL TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$838.31M	Jun 27, 26	at low
3Y	$838.31M	Jun 27, 26	at low
5Y	$806.78M	N/A	+3.9%
All	$20.99M	Mar 31, 00	+3893.6%

TTM EBITDA History

Month	Value	Change
Jun 2026	$838.31M	-3.9%
Mar 2026	$872.61M	-3.5%
Dec 2025	$904.26M	-0.4%
Sep 2025	$907.49M	-0.0%
Jun 2025	$907.79M	-0.4%
Mar 2025	$911.64M	-1.0%
Dec 2024	$921.09M	-3.2%
Sep 2024	$951.40M	-1.0%
Jun 2024	$961.42M	+1.2%
Mar 2024	$949.57M	-1.8%
Dec 2023	$967.26M	-0.9%
Sep 2023	$975.66M	+2.1%
Jun 2023	$955.78M	-2.2%
Mar 2023	$977.13M	+1.3%
Dec 2022	$964.29M	-1.2%
Sep 2022	$976.34M	-0.7%
Jun 2022	$983.08M	+4.5%
Mar 2022	$940.45M	+4.2%
Dec 2021	$902.42M	+6.7%
Sep 2021	$845.58M	+4.8%
Jun 2021	$806.78M	+10.8%
Mar 2021	$727.84M	+5.2%
Dec 2020	$691.88M	+3.6%
Sep 2020	$668.01M	+6.9%
Jun 2020	$624.61M	+0.1%
Mar 2020	$623.69M	+6.3%
Dec 2019	$586.59M	+4.4%
Sep 2019	$562.08M	+3.2%
Jun 2019	$544.70M	+1.6%
Mar 2019	$536.05M	+3.1%
Dec 2018	$519.86M	+10.6%
Sep 2018	$470.21M	+5.4%
Jun 2018	$446.20M	+4.7%
Mar 2018	$426.10M	+0.2%
Dec 2017	$425.30M	-1.9%
Sep 2017	$433.52M	+3.4%
Jun 2017	$419.12M	+3.6%
Mar 2017	$404.58M	+6.6%
Dec 2016	$379.35M	+7.6%
Sep 2016	$352.54M	+3.6%
Jun 2016	$340.37M	+6.1%
Mar 2016	$320.95M	+4.7%
Dec 2015	$306.49M	+0.3%
Sep 2015	$305.51M	+3.4%
Jun 2015	$295.58M	+0.4%
Mar 2015	$294.28M	+1.3%
Dec 2014	$290.51M	+4.6%
Sep 2014	$277.70M	+1.9%
Jun 2014	$272.60M	+5.7%
Mar 2014	$257.80M	-0.5%
Dec 2013	$259.22M	+1.6%
Sep 2013	$255.16M	+2.2%
Jun 2013	$249.67M	-2.1%

Month	Value	Change
Mar 2013	$255.13M	-0.6%
Dec 2012	$256.71M	-5.3%
Sep 2012	$271.01M	+1.5%
Jun 2012	$266.88M	-2.6%
Mar 2012	$274.04M	+0.2%
Dec 2011	$273.46M	+2.5%
Sep 2011	$266.83M	-0.5%
Jun 2011	$268.22M	+9.2%
Mar 2011	$245.65M	+3.2%
Dec 2010	$238.02M	+2.8%
Sep 2010	$231.53M	-4.8%
Jun 2010	$243.25M	-7.5%
Mar 2010	$262.88M	-4.6%
Dec 2009	$275.44M	-3.8%
Sep 2009	$286.39M	-1.4%
Jun 2009	$290.48M	-6.1%
Mar 2009	$309.26M	-5.2%
Dec 2008	$326.09M	-1.0%
Sep 2008	$329.39M	+1.2%
Jun 2008	$325.62M	+9.2%
Mar 2008	$298.14M	+3.9%
Dec 2007	$286.93M	+7.7%
Sep 2007	$266.45M	-0.1%
Jun 2007	$266.60M	-0.2%
Mar 2007	$267.00M	+3.0%
Dec 2006	$259.22M	-4.1%
Sep 2006	$270.25M	+1.4%
Jun 2006	$266.47M	+1.8%
Mar 2006	$261.74M	-1.5%
Dec 2005	$265.72M	+3.9%
Sep 2005	$255.70M	+7.6%
Jun 2005	$237.53M	+3.8%
Mar 2005	$228.90M	+11.4%
Dec 2004	$205.43M	+6.3%
Sep 2004	$193.23M	+4.8%
Jun 2004	$184.46M	+5.1%
Mar 2004	$175.57M	+3.4%
Dec 2003	$169.74M	+3.8%
Sep 2003	$163.57M	+1.6%
Jun 2003	$160.94M	+4.6%
Mar 2003	$153.93M	+5.2%
Dec 2002	$146.25M	+2.5%
Sep 2002	$142.66M	+5.7%
Jun 2002	$134.98M	+3.8%
Mar 2002	$130.07M	+7.5%
Dec 2001	$121.03M	+14.9%
Sep 2001	$105.33M	+9.4%
Jun 2001	$96.27M	+9.8%
Mar 2001	$87.64M	+4.6%
Dec 2000	$83.82M	+27.9%
Sep 2000	$65.56M	+50.9%
Jun 2000	$43.45M	+107.0%
Mar 2000	$20.99M	-

FAQ

What is the current TTM EBITDA of CRL?: As of today, CRL TTM EBITDA is $838.31M
What is CRL TTM EBITDA most recent change?: CRL TTM EBITDA was down -3.93% on June 27, 2026
What is 1-year change in CRL TTM EBITDA?: CRL TTM EBITDA is down -7.65% year-over-year
How far is CRL TTM EBITDA from its all-time high?: CRL TTM EBITDA is currently -14.73% below its historical high of $983.08M set on June 25, 2022
How does CRL TTM EBITDA rank versus sector peers?: CRL TTM EBITDA is higher than 92.25% of companies in Healthcare sector
When is CRL next earnings release?: The next earnings release for CRL is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

CRL Official Website www.criver.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1100682/000110068226000022/0001100682-26-000022-index.htm
CRL Profile on Yahoo Finance finance.yahoo.com/quote/CRL
CRL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crl